Webside score daiichisankyo.us

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

Genereret Marts 12 2026 17:06 PM

Gammel data? OPDATER !

Scoren er 54/100

SEO Indhold

Titel

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

Længde : 67

Perfekt, din titel indeholder mellem 10 og 70 bogstaver.

Beskrivelse

Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.

Længde : 130

Perfekt, din meta beskrivelse indeholder mellem 70 og 160 karakterer.

Nøgleord

home, homepage, landing

Godt, din side indeholder meta nøgleord.

Og Meta Egenskaber

Godt, din side benytter Og egenskaberne

Egenskab	Indhold
description	Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.
locale	en_US
locale:alternate	en_US
site_name	DSI
title	Passion for innovation. Compassion for patients.
type	website
url	https://daiichisankyo.us

Overskrifter

H1	H2	H3	H4	H5	H6
1	34	0	0	0	0

[H1] Passion for Innovation. Compassion for Patients.®
[H2] Search Bar
[H2] Menu Display
[H2] Who We Are
[H2] Strategy
[H2] Purpose
[H2] Partners
[H2] Leadership
[H2] History
[H2] Patient Advocacy
[H2] Our Crafts
[H2] Compliance +
[H2] Transparency and Disclosure +
[H2] Corporate Grants and Giving +
[H2] Daiichi Sankyo Patient Support Programs
[H2] Supplier Diversity +
[H2] Transparency in Coverage
[H2] Rights & Protections Against Surprise Medical Bills
[H2] Our Science
[H2] Our Pipeline
[H2] Worldwide R&D Operations
[H2] Clinical Trial Information Disclosure
[H2] Expanded Access to Investigational Products
[H2] External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR)
[H2] Breadcrumb
[H2] Creating New Standards of Care
[H2] Our Stories
[H2] Asset Publisher
[H2] Transforming Science into Medicines
[H2] Striving to Create Optimized Antibody Drug Conjugate (ADC) Technology
[H2] What's New
[H2] Asset Publisher
[H2] A Pipeline Pushing Us to Become a Global Leader in Oncology
[H2] Work with a Purpose
[H2] Menu Display

Billeder

Vi fandt 12 billeder på denne side.

1 alt tags mangler eller er tomme. Tilføj alternativ tekst til dine billeder for at gøre siden mere brugervenlig, og for at optimere din SEO i forhold til søgemaskinerne.

Text/HTML balance

Balance : 37%

Optimalt! Denne sides text til HTML fordeling er mellem 25 og 70 procent.

Flash

Perfekt, ingen Flash objekter er blevet fundet på siden.

iFrame

Beklager! Din side har iFrames og det kan medføre i yderst dårlig læsning af søgerobotterne.

SEO Links

URL Omskrivning

Godt. Dine links ser venlige ud!

Underscores i links

Dårligt! Vi har fundet underscores i dine links, du bør benytte bindestreg istedet for underscores for at optimere din SEO.

On-page links

Vi fandt et total af 61 links inkluderende 0 link(s) til filer

Anker	Type	Juice
Skip to content	Intern	Sender Juice
Healthcare Professionals	Ekstern	Sender Juice
Careers	Intern	Sender Juice
Contact Us	Intern	Sender Juice
Worldwide	Ekstern	Sender Juice
About Us	Intern	Sender Juice
Who We Are	Intern	Sender Juice
Strategy	Intern	Sender Juice
Purpose	Intern	Sender Juice
Partners	Intern	Sender Juice
Leadership	Intern	Sender Juice
History	Intern	Sender Juice
Patient Advocacy	Intern	Sender Juice
Our Crafts	Intern	Sender Juice
Compliance	Intern	Sender Juice
Standards Of Business Conduct	Intern	Sender Juice
Standards of Business Conduct & Ethics for Third Parties	Intern	Sender Juice
Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy	Intern	Sender Juice
California Compliance Declaration	Intern	Sender Juice
California Supply Chains Act	Intern	Sender Juice
Daiichi Sankyo Group Employee Code of Conduct	Intern	Sender Juice
Transparency and Disclosure	Intern	Sender Juice
Post-marketing Commitments	Intern	Sender Juice
Working with Healthcare Professionals	Intern	Sender Juice
Vermont Pharmaceutical Marketer Price Disclosure	Intern	Sender Juice
Clinical Trial Information Disclosure	Ekstern	Sender Juice
Corporate Grants and Giving	Intern	Sender Juice
Independent Grants	Intern	Sender Juice
Sponsorships	Intern	Sender Juice
Charitable Contributions	Intern	Sender Juice
Daiichi Sankyo Requirements	Intern	Sender Juice
Corporate Support FAQs	Intern	Sender Juice
Daiichi Sankyo Patient Support Programs	Intern	Sender Juice
Supplier Diversity	Intern	Sender Juice
Supplier Registration	Intern	Sender Juice
Supplier Diversity FAQs	Intern	Sender Juice
Transparency in Coverage	Intern	Sender Juice
Rights & Protections Against Surprise Medical Bills	Intern	Sender Juice
Our Science	Intern	Sender Juice
Our Pipeline	Ekstern	Sender Juice
Worldwide R&D Operations	Ekstern	Sender Juice
Expanded Access to Investigational Products	Ekstern	Sender Juice
External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR)	Ekstern	Sender Juice
Medicines	Intern	Sender Juice
Media	Intern	Sender Juice
Our Stories	Intern	Sender Juice
Home	Intern	Sender Juice
Learn More About Our Purpose	Intern	Sender Juice
View More Stories	Intern	Sender Juice
HER2 in Gynecologic Cancers—Why It Matters	Intern	Sender Juice
Showing Up for Patients: CARE Teams Inspire Hope in Their Communities	Intern	Sender Juice
Learn More About Our Science	Intern	Sender Juice
Explore the DXd ADC Technology Website	Ekstern	Sender Juice
View More News	Intern	Sender Juice
Patent Dispute Between Daiichi Sankyo and Seagen has Concluded	Intern	Sender Juice
ENHERTU Granted Priority Review in the US as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer	Intern	Sender Juice
Learn More About Our Medicines	Intern	Sender Juice
Terms & Conditions	Intern	Sender Juice
Privacy Notice	Intern	Sender Juice
Site Map	Intern	Sender Juice
Return	Ekstern	Sender Juice

SEO Nøgleord

Nøgleords cloud

adverse dose reactions enhertu decreased metastatic cancer patients count treatment

Nøgleords balance

Nøgleord	Indhold	Titel	Nøgleord	Beskrivelse	Overskrifter
patients	159
enhertu	159
decreased	89
adverse	60
count	55

Brugervenlighed

Link

Domæne : daiichisankyo.us

Længde : 16

FavIkon

Godt, din side har et FavIcon!

Printervenlighed

Vi kunne ikke finde en printer venlig CSS skabelon.

Sprog

Godt, dit tildelte sprog er en.

Dublin Core

Denne side benytter IKKE Dublin Core principperne.

Dokument

Dokumenttype

HTML 5

Kryptering

Perfekt. Dit Charset er tildelt UTF-8.

W3C Validering

Fejl : 0

Advarsler : 0

Email Privatliv

Advarsel! Mindst én email adresse er blevet fundet i rå tekst. Brug gratis antispam beskytter for at hemme din email fra spammere.

Udgået HTML

Godt! Vi har ikke fundet udgåede HTML tags i din kildekode

Hastigheds Tips

	Alle tiders! Din webside bruger ikke nestede tabeller.
	Advarsel! Din webside benytter inline CSS kode!
	Dårligt, din webside har for mange CSS filer (mere end 4).
	Dårligt, din webside har for mange JavaScript filer (mere end 6).
	Ærgerligt, din hjemmeside ikke udnytte gzip.

Mobil

Mobil Optimering

	Apple Ikon
	Meta Viewport Tag
	Flash indhold

Optimering

XML Sitemap

Stor, din hjemmeside har en XML sitemap.

https://daiichisankyo.us/sitemap.xml

Robots.txt

https://daiichisankyo.us/robots.txt

Stor, din hjemmeside har en robots.txt-fil.

Analytics

Stor, din hjemmeside har et analyseværktøj.

Google Analytics

PageSpeed Insights

Apparat

Computer

Mobil

Kategorier

Effektivitet

Hjælpefunktioner

Optimale løsninger

SEO

Progressiv webapp

Free SEO Testing Tool

Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside